US 10711068
Anti-CD133 monoclonal antibodies and related compositions and methods
granted A61KA61K2039/505A61P
Quick answer
US patent 10711068 (Anti-CD133 monoclonal antibodies and related compositions and methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00